We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PITTSBURGH, Feb. 25 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced the appointment of John D. Sheehan as Executive Vice President and Chief Financial Officer. Sheehan has...
PITTSBURGH, Feb. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) announced today that it will host a conference call and live webcast on Thursday, Feb. 25, 2010, at 10 a.m. ET, to review the...
PITTSBURGH, Jan. 29 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug...
PITTSBURGH, Nov. 18 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced that Didier Barret, president of Mylan Europe, Middle East and Africa (EMEA), has been elected president of...
Mylan Inc. (MYL) swung to a third-quarter loss, weighed down by litigation and acquisition-related expenses, as its core operational performance exceeded Wall Street expectations. The Pittsburgh...
By Val Brickates Kennedy U.S. drug stocks edged higher in early trading Thursday, with shares of biotech groups BioMarin Pharmaceutical Inc. and Human Genome Sciences leading the pack. The NYSE...
Mylan Inc. (MYL) swung to a third-quarter loss, weighed down by litigation and acquisition-related expenses, as its core operational performance exceeded Wall Street expectations. The Pittsburgh...
Mylan Inc. (MYL) swung to a third-quarter loss due to its $121 million settlement of a Medicaid-rebate case, masking higher generic drug revenue. But core results beat Wall Street estimates...
Three pharmaceutical companies agreed to a $124 million settlement to resolve claims they failed to pay rebates for some state Medicaid programs, the U.S. Justice Department announced Monday...
Mylan Inc. (MYL) and other drug makers have paid $124 million to settle charges that they underpaid their rebate obligations to state Medicaid programs, the U.S. Justice Department announced...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0.025 | 55.5555555556 | 0.045 | 0.1175 | 0.023 | 3275456 | 0.06900602 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions